For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Caredx Inc (NASDAQ: CDNA) closed at $22.37 in the last session, up 1.41% from day before closing price of $22.06. In other words, the price has increased by $1.41 from its previous closing price. On the day, 0.57 million shares were traded. CDNA stock price reached its highest trading level at $22.525 during the session, while it also had its lowest trading level at $21.62.
Ratios:
We take a closer look at CDNA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 983.43. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 4.10. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Underweight rating and assigned the stock a target price of $28.
On August 19, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when JEFFREY NOVACK bought 5,534 shares for $21.17 per share.
Johnson Alexander L sold 39,466 shares of CDNA for $1,309,087 on Aug 20 ’24. The insider now owns 284,983 shares after completing the transaction at $33.17 per share. On Aug 21 ’24, another insider, Johnson Alexander L, who serves as the insider of the company, sold 21,557 shares for $32.58 each. As a result, the insider received 702,327 and left with 284,983 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1199790336 and an Enterprise Value of 988901696. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.84 while its Price-to-Book (P/B) ratio in mrq is 4.35. Its current Enterprise Value per Revenue stands at 3.162 whereas that against EBITDA is -22.346.
Stock Price History:
Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $7.42. The 50-Day Moving Average of the stock is -14.97%, while the 200-Day Moving Average is calculated to be 22.91%.
Shares Statistics:
According to the various share statistics, CDNA traded on average about 848.79K shares per day over the past 3-months and 858870 shares per day over the past 10 days. A total of 51.50M shares are outstanding, with a floating share count of 50.16M. Insiders hold about 6.48% of the company’s shares, while institutions hold 97.23% stake in the company. Shares short for CDNA as of 1730332800 were 3448286 with a Short Ratio of 4.06, compared to 1727654400 on 3658174. Therefore, it implies a Short% of Shares Outstanding of 3448286 and a Short% of Float of 8.48.
